Top Injectable Manufacturer in Pakistan – Reliable Pharmaceutical Solutions
- Maulik Sudani
- Jul 7
- 7 min read
Last Updated: July 7, 2026
TL;DR: Pakistan — the world's fifth-most-populous country, with more than 240 million people served through public health departments, the Sehat Sahulat programme and a large private sector — needs a dependable, compliant supply of sterile injectables for its hospitals, tender programmes and immunisation and disease-control drives. A significant share of finished injectables and most active ingredients are imported, and every imported product must be registered with the Drug Regulatory Authority of Pakistan (DRAP), brought in through a licensed importer, manufactured to WHO-GMP standards and labelled for the local market. Farbe Firma Pvt Ltd is a WHO-GMP certified injectable manufacturer in Pakistan's supply chain and a CDMO in Gujarat, India, producing more than 100 sterile injectables under ISO Class 5 aseptic conditions and exporting to 30+ countries, with complete CTD/ACTD dossiers, drug master files and ICH stability data ready to support DRAP registration and hospital- and provincial-tender qualification for Pakistani partners.
Key Takeaways
Market and regulatory pathway: every sterile injectable entering Pakistan must be registered with the Drug Regulatory Authority of Pakistan (DRAP) under the DRAP Act 2012, imported through a licensed importer, manufactured under WHO-GMP and labelled for the local market; Farbe Firma builds every dossier and supply arrangement around DRAP's requirements, including its registration and pricing framework.
Certified manufacturing: WHO-GMP certified plant with an ISO Class 5 aseptic core, validated water-for-injection loops, terminal moist-heat sterilisation where the formulation qualifies and full aseptic processing where it does not, HPLC and LAL testing and 100% visual inspection on every batch.
CTD/ACTD dossier support: full eCTD and ACTD modules, ICH Q1A long-term and accelerated stability and ICH Q1B photostability data, sterilisation and container-closure packages, drug master files and CEP-style documentation for DRAP registration, provincial-health-department and institutional tenders.
End-to-end CDMO services: contract and third-party manufacturing across 100+ sterile injectables — ampoules, vials, lyophilised products and pre-filled presentations — with market-appropriate English/Urdu artwork and leaflets, tamper-evident tender-ready packaging and import/export coordination to Karachi, Lahore and beyond.
Introduction: Why an Injectable Manufacturer in Pakistan Must Meet Global Standards
Pakistan is the fifth-most-populous country in the world, with more than 240 million people and one of the youngest, fastest-growing populations anywhere. Its healthcare is delivered through a mix of federal and provincial public systems, the Sehat Sahulat social-health-protection programme and a very large private sector, and across all of them the demand for sterile injectables is enormous. The country carries one of the world's heaviest infectious-disease burdens — among the highest rates of hepatitis B and C, a major tuberculosis burden, recurrent dengue and drug-resistant typhoid outbreaks — while remaining one of only a handful of polio-endemic countries, which keeps its Expanded Programme on Immunization (EPI) permanently active. Antibiotics, anaesthetics, emergency and critical-care drugs, maternal and neonatal injectables and vaccines all have to reach hospitals and clinics sterile, correctly labelled and exactly to specification, batch after batch.
Although Pakistan has a large domestic pharmaceutical industry, it still imports a significant share of its finished sterile injectables and the majority of its active pharmaceutical ingredients, so a reliable overseas manufacturing partner is strategically important. That partner must clear a demanding regulatory pathway: every product must be registered with the Drug Regulatory Authority of Pakistan (DRAP), the national regulator established under the DRAP Act 2012, and imported through a licensed importer holding the registration; the manufacturing site must meet WHO-GMP; the label, leaflet and pack must suit the local market, with English and Urdu as required; and pricing sits within DRAP's regulated framework. An injectable manufacturer that wants to serve Pakistan well has to treat these requirements not as afterthoughts but as core design inputs — which is exactly how Farbe Firma approaches the market.
What Sets a World-Class Injectable Manufacturer in Pakistan Apart
The first differentiator is genuine sterile-manufacturing capability. A world-class injectable manufacturer serving Pakistan runs a WHO-GMP certified plant with an ISO Class 5 (Grade A) aseptic core, validated water-for-injection generation and looped distribution, qualified HVAC with continuous environmental monitoring, and both terminal moist-heat sterilisation and full aseptic processing so that each product is made by the route its formulation and container actually justify. It backs that with a proper analytical laboratory — stability-indicating HPLC assay and related-substance control, bacterial endotoxin testing by LAL, sterility testing, and particulate and container-closure-integrity checks — and a broad, registered portfolio of more than 100 injectables in ampoule, vial, lyophilised and pre-filled formats, so a Pakistani importer or hospital group can consolidate many product needs with a single qualified source.
The second differentiator is registration and market-access support built specifically around Pakistan. DRAP accepts CTD and ACTD-format submissions, so a strong partner prepares complete, review-ready CTD/eCTD and ACTD modules with ICH Q1A stability and ICH Q1B photostability data, drug master files, sterilisation and container-closure reports and method-validation packages — the documentation a licensed importer's regulatory team needs to file a registration without gaps or delays. It supplies market-appropriate artwork and package inserts in English and Urdu, works within DRAP's registration and price-fixing framework, and packages products to be tender-ready for the provincial health departments, autonomous hospitals and institutional buyers that channel much of Pakistan's public-sector demand. This combination of manufacturing depth and Pakistan-specific dossier and labelling support is what separates a true injectable manufacturer in Pakistan's supply chain from a mere exporter.
Quality Systems Behind Every Batch We Ship to Pakistan
Every Farbe Firma injectable batch destined for Pakistan is released only after a full stack of quality checks: stability-indicating HPLC assay against pharmacopoeial reference standards, control of related substances and degradation products, solution pH and clarity, deliverable volume, visible and sub-visible particulate matter, bacterial endotoxin by LAL, sterility by membrane filtration, and container-closure integrity for the ampoule, vial or pre-filled format. Certificates of analysis are issued with full traceability back to each API lot, the primary-packaging lot and the qualified person responsible for release, so an importer's regulatory-affairs team and DRAP reviewers can see a complete, auditable chain from raw material to finished unit.
Around those release tests sits a deeper quality architecture: validated water-for-injection systems, qualified and monitored cleanrooms, validated sterilisation and depyrogenation equipment, validated filling lines with 100% inspection, and an electronic batch-record system tied into formal deviation, change-control and CAPA workflows. Stability is tracked under both long-term (30 °C / 75 % RH, the ICH Zone IVb condition appropriate to Pakistan's hot climate) and accelerated (40 °C / 75 % RH) conditions, with a photostability challenge where relevant, so registered shelf lives are supported by data generated under conditions that reflect how the product will actually be stored and transported from Karachi and Lahore to the provinces.
Looking for a sterile injectable manufacturing partner? Submit a Quick Inquiry
Why Farbe Firma is the Trusted Injectable Manufacturer in Pakistan for Global Buyers
Farbe Firma Pvt Ltd manufactures more than 100 sterile injectables at its WHO-GMP certified facility in Gujarat, India, spanning antibiotic, anaesthesia, emergency and critical-care, gastrointestinal, anti-emetic, analgesic, vitamin and specialty ranges — the categories Pakistani hospitals, distributors and government programmes buy in the largest volumes. For Pakistani partners we supply finished sterile injectables ready for DRAP registration, with market-specific strengths, fill volumes, English/Urdu artwork and tamper-evident tender packs available under contract-manufacturing agreements, and every batch released to WHO-GMP standards with its CTD/ACTD data package ready for the importer's registration filing.
Our CDMO services scale cleanly from a single distributor's launch portfolio to full provincial- and federal-tender supply. We prepare complete CTD/eCTD and ACTD modules, drug master files, ICH Q1A stability and ICH Q1B photostability packages, assay and related-substance method-validation data, sterilisation and container-closure reports, and translated English/Urdu inserts and artwork, and we work within DRAP's registration and pricing requirements alongside the importer. Our regulatory, manufacturing and logistics teams coordinate registration timelines, line slots and shipping to Karachi, Lahore and other ports of entry as a single, managed programme rather than a series of disconnected transactions.
Buyers stay with Farbe Firma because of audit-readiness and communication. Pakistani importers and their auditors are welcomed onto the plant floor and into the compounding and filling suites; our quality unit answers technical and regulatory queries with primary data rather than slogans; and our reviewer team — practising pharmacists and R&D scientists — can talk through API sourcing, sterile-process design, stability strategy for a Zone IVb climate, CTD/ACTD dossier structure, DRAP registration and pricing steps and tender documentation in real detail. For an importer or hospital group that has to answer to DRAP, to provincial health departments and to its own patients, that transparency is exactly what makes a distant manufacturer feel like a dependable local partner.
Explore Farbe Firma: Products | Global Reach | About Us
Frequently Asked Questions (FAQ)
Is Farbe Firma a WHO-GMP certified injectable manufacturer that can supply Pakistan?
Yes. Farbe Firma Pvt Ltd holds WHO-GMP certification and manufactures more than 100 sterile injectables at its Gujarat, India facility with ISO Class 5 aseptic processing, validated water-for-injection systems, terminal and aseptic sterilisation routes, HPLC and LAL testing, 100% inspection and continuous environmental monitoring. We already export to 30+ countries and prepare every batch and dossier to support import and DRAP registration in Pakistan through a licensed importer.
How does Farbe Firma support DRAP registration for injectables in Pakistan?
We provide complete CTD/eCTD and ACTD modules, drug master files, ICH Q1A stability and ICH Q1B photostability data, sterilisation and container-closure reports and method-validation packages — the technical documentation a licensed Pakistani importer's regulatory team needs to file a drug registration with the Drug Regulatory Authority of Pakistan (DRAP). We also supply market-appropriate English/Urdu artwork and package inserts and support the site-GMP documentation DRAP expects.
Which injectables can Farbe Firma supply to Pakistani hospitals and tenders?
Our portfolio of 100+ sterile injectables covers antibiotics, anaesthetics, emergency and critical-care drugs, analgesics, anti-emetics, gastrointestinal agents, vitamins and specialty products in ampoule, vial, lyophilised and pre-filled formats. We package products to be tender-ready for provincial health department and autonomous-hospital tenders and for EPI-linked supply, with market-specific strengths and pack sizes available under contract.
Can Farbe Firma meet Pakistan's labelling and pricing requirements?
Yes. We provide market-specific artwork and package inserts in English and Urdu as required, and we work within DRAP's registration and price-fixing framework together with the local importer, who holds the registration and the approved maximum retail price. This lets registered products meet Pakistan's labelling and pricing rules while keeping the WHO-GMP quality and dossier standard consistent with our other markets.
What is the minimum order quantity for injectable contract manufacturing for Pakistan?
MOQs vary by product, format, sterilisation route, label complexity and dossier requirements. We accommodate single-distributor launch quantities as well as full provincial- and federal-tender-scale supply for the Pakistani market. Contact director@farbefirma.org for a specific quotation and a registration and supply plan for your product list.
Technically Reviewed By: Maulik Sudani | Jignasu Sudani (Technical Expert)
Website: www.farbefirma.org | Email: director@farbefirma.org | Address: Gujarat, INDIA
Request a Quote | View Products | FAQ | Blog
Comments